These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 32080807)
1. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma. Ji L; Dong C; Fan R; Qi S Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807 [TBL] [Abstract][Full Text] [Related]
2. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application. Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171 [TBL] [Abstract][Full Text] [Related]
3. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody]. Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599 [TBL] [Abstract][Full Text] [Related]
4. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line. Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340 [TBL] [Abstract][Full Text] [Related]
5. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related]
6. Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein. Li T; Huang M; Xiao H; Zhang G; Ding J; Wu P; Zhang H; Sheng J; Chen C PLoS One; 2017; 12(6):e0178469. PubMed ID: 28582444 [TBL] [Abstract][Full Text] [Related]
7. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii. Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583 [TBL] [Abstract][Full Text] [Related]
8. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library. Kavousipour S; Mokarram P; Gargari SLM; Mostafavi-Pour Z; Barazesh M; Ramezani A; Ashktorab H; Mohammadi S; Ghavami S Protein Pept Lett; 2018; 25(6):580-588. PubMed ID: 29848261 [TBL] [Abstract][Full Text] [Related]
9. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor. Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350 [TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma. Xia L; Teng Q; Chen Q; Zhang F Int J Nanomedicine; 2020; 15():2197-2205. PubMed ID: 32280214 [TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a human nanobody against VEGFR-2. Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602 [TBL] [Abstract][Full Text] [Related]
12. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library. Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262 [TBL] [Abstract][Full Text] [Related]
13. [Preliminary Study on Screening and Identification of Lewis a Antigen Mimic Epitope in Alpaca Phage Display Nanobody Library]. Zhong XL; Yang L; Zhang J; Sun LP; Ma MZ; Fan B; Shang W; Huang YS; Wang DQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):877-883. PubMed ID: 35680821 [TBL] [Abstract][Full Text] [Related]
14. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers. Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715 [TBL] [Abstract][Full Text] [Related]
15. Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R. Meng N; Cheng X; Sun M; Zhang Y; Sun X; Liu X; Chen J Int J Nanomedicine; 2023; 18():7173-7181. PubMed ID: 38076734 [TBL] [Abstract][Full Text] [Related]
16. A novel nanobody against urease activity of Helicobacter pylori. Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799 [TBL] [Abstract][Full Text] [Related]
17. Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1). Wen B; Zhao L; Wang Y; Qiu C; Xu Z; Huang K; Zhu H; Li Z; Li H Prep Biochem Biotechnol; 2020; 50(3):252-259. PubMed ID: 31799894 [TBL] [Abstract][Full Text] [Related]
18. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library. Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494 [TBL] [Abstract][Full Text] [Related]
19. A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis. Araste F; Ebrahimizadeh W; Rasooli I; Rajabibazl M; Mousavi Gargari SL Biotechnol Lett; 2014 Jan; 36(1):21-8. PubMed ID: 24068505 [TBL] [Abstract][Full Text] [Related]
20. Screening, expression and anti-tumor functional identification of anti-LAG-3 nanobodies. Jiang D; Chen R; Wang L; Xu G Protein Expr Purif; 2024 Oct; 222():106522. PubMed ID: 38851552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]